Sunshine Biopharma, Inc. (SBFM) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 8.09M | 8.58M | 9.42M | 9.41M | 8.9M | 9.59M | 8.44M | 9.3M | 7.54M | 7.68M | 5.96M | 5.56M |
| Revenue Growth % | -9.13% | -10.6% | 11.64% | 1.15% | 18.04% | 24.93% | 41.59% | 67.3% | 54.09% | 94.94% | 4385.93% | 3599.67% |
| Cost of Goods Sold | 5.98M | 5.65M | 6.34M | 5.99M | 6.17M | 6.5M | 5.57M | 6.95M | 5.19M | 5.11M | 3.97M | 3.61M |
| COGS % of Revenue | 73.99% | 65.84% | 67.36% | 63.63% | 69.33% | 67.76% | 66.02% | 74.67% | 68.78% | 66.56% | 66.59% | 64.88% |
| Gross Profit | 2.1M | 2.93M | 3.07M | 3.42M | 2.73M | 3.09M | 2.87M | 2.36M | 2.35M | 2.57M | 1.99M | 1.95M |
| Gross Margin % | 26.01% | 34.16% | 32.64% | 36.37% | 30.67% | 32.24% | 33.98% | 25.33% | 31.22% | 33.44% | 33.41% | 35.12% |
| Gross Profit Growth % | -22.94% | -5.27% | 7.24% | 45.27% | 15.97% | 20.44% | 44.01% | 20.66% | 28.78% | 72.22% | 2869.42% | 2482.18% |
| Operating Expenses | 3.5M | 4.59M | 3.61M | 4.42M | 4.03M | 5.13M | 3.97M | 3.62M | 3.7M | 3.76M | 2.77M | 2.97M |
| OpEx % of Revenue | 43.27% | 53.49% | 38.29% | 46.92% | 45.23% | 53.47% | 47.09% | 38.96% | 49.13% | 48.9% | 46.49% | 53.35% |
| Selling, General & Admin | 3.34M | 8.69M | 3.27M | 4.03M | 3.64M | 4.81M | 3.73M | 2.99M | 3.36M | 2.82M | 2.44M | 2.47M |
| SG&A % of Revenue | 41.27% | 101.26% | 34.73% | 42.87% | 40.85% | 50.1% | 44.16% | 32.16% | 44.61% | 36.72% | 40.99% | 44.36% |
| Research & Development | 31.72K | -530.81K | 119.3K | 196.23K | 215.28K | 149.27K | 126.36K | 436.24K | 222.03K | 816.33K | 238.01K | 368.56K |
| R&D % of Revenue | 0.39% | -6.19% | 1.27% | 2.09% | 2.42% | 1.56% | 1.5% | 4.69% | 2.94% | 10.63% | 4% | 6.63% |
| Other Operating Expenses | 129.66K | -1000K | 215.73K | 185.21K | 174.97K | 174.24K | 121.1K | 196.67K | 118.52K | 119.13K | 89.8K | 131.53K |
| Operating Income | -1.4M | -1.66M | -531.96K | -992.85K | -1.3M | -2.04M | -1.11M | -1.27M | -1.35M | -1.19M | -779.47K | -1.01M |
| Operating Margin % | -17.25% | -19.33% | -5.65% | -10.55% | -14.56% | -21.24% | -13.12% | -13.63% | -17.91% | -15.46% | -13.08% | -18.23% |
| Operating Income Growth % | -7.71% | 18.62% | 51.92% | 21.72% | 4.06% | -71.64% | -41.94% | -25.09% | 26.16% | 94.92% | 54.63% | -45.72% |
| EBITDA | -1.32M | -1.56M | -435.8K | -920.31K | -1.23M | -1.97M | -1.04M | -1.22M | -1.31M | -1.14M | -742.27K | -979K |
| EBITDA Margin % | -16.3% | -18.18% | -4.63% | -9.78% | -13.83% | -20.56% | -12.35% | -13.09% | -17.34% | -14.91% | -12.46% | -17.61% |
| EBITDA Growth % | -7.13% | 20.92% | 58.17% | 24.4% | 5.89% | -72.27% | -40.34% | -24.35% | 27.1% | 95.1% | 56.77% | -41.17% |
| D&A (Non-Cash Add-back) | 76.86K | 98.58K | 96.16K | 72.53K | 64.79K | 65.41K | 64.63K | 50.88K | 42.62K | 42.35K | 37.2K | 34.88K |
| EBIT | -1.24M | -1.73M | -1.02M | -1.98M | -1.22M | -2.28M | -982.59K | -837.75K | -1.21M | -999.65K | -572K | -811.1K |
| Net Interest Income | 48.43K | 57.47K | 75.35K | 72.72K | 75.37K | 90.78K | 108.61K | 143.75K | 94.91K | 157.5K | 168.9K | 199.72K |
| Interest Income | 48.43K | 57.47K | 75.35K | 72.72K | 75.37K | 99.31K | 108.61K | 144K | 144.09K | 187.61K | 207.43K | 203.05K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 8.53K | 0 | 245 | 49.18K | 30.11K | 38.53K | 3.33K |
| Other Income/Expense | 151.73K | -74.33K | -489.3K | -987.15K | 75.82K | -249.23K | 123.77K | 430.29K | 89.14K | 157.46K | 168.94K | 199.46K |
| Pretax Income | -1.24M | -1.73M | -1.02M | -1.98M | -1.22M | -2.29M | -982.59K | -837.99K | -1.26M | -1.03M | -610.53K | -814.43K |
| Pretax Margin % | -15.38% | -20.2% | -10.84% | -21.04% | -13.71% | -23.83% | -11.65% | -9.01% | -16.73% | -13.41% | -10.25% | -14.65% |
| Income Tax | 0 | 408.37K | -137.44K | -209.17K | -40.16K | -128.74K | 215.22K | -343.69K | 22.35K | 220.27K | 40.95K | 87.68K |
| Effective Tax Rate % | 0% | -23.57% | 13.46% | 10.56% | 3.29% | 5.63% | -21.9% | 41.01% | -1.77% | -21.39% | -6.71% | -10.77% |
| Net Income | -1.24M | -2.14M | -883.82K | -1.77M | -1.18M | -2.16M | -1.2M | -494.3K | -1.28M | -1.25M | -651.48K | -902.11K |
| Net Margin % | -15.38% | -24.96% | -9.39% | -18.82% | -13.25% | -22.49% | -14.2% | -5.31% | -17.02% | -16.28% | -10.94% | -16.22% |
| Net Income Growth % | -5.43% | 0.81% | 26.21% | -258.25% | 8.1% | -72.65% | -83.86% | 45.21% | 24.59% | 94.68% | 55.29% | -67.41% |
| Net Income (Continuing) | -1.24M | -2.14M | -883.82K | -1.77M | -1.18M | -2.16M | -1.2M | -494.3K | -1.28M | -1.25M | -651.48K | -902.11K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.50 | -4.60 | -1.90 | -78.00 | -4.40 | -8.40 | -9.40 | -99.40 | -400.40 | -1046.90 | -507.20 | -7.10 |
| EPS Growth % | 43.18% | 45.24% | 79.79% | 21.53% | 98.9% | 99.2% | 98.15% | -1300% | 74.09% | -9966.35% | 68.3% | 98.82% |
| EPS (Basic) | -2.50 | -4.60 | -1.90 | -78.00 | -4.40 | -8.40 | -9.40 | -99.40 | -400.40 | -1046.90 | -507.20 | -7.10 |
| Diluted Shares Outstanding | 490.6K | 415.71K | 465.17K | 22.48K | 270.3K | 258K | 126.8K | 4.97K | 3.21K | 1.19K | 1.28K | 126.8K |
| Basic Shares Outstanding | 490.6K | 415.71K | 465.17K | 22.48K | 270.3K | 258K | 126.8K | 4.97K | 3.21K | 1.19K | 1.28K | 126.8K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |